About Index Trending news
Analyze
Pricing
Promethera Biosciences

Promethera Biosciences

Work at Promethera Biosciences? Add yourself to this profile

Promethera Biosciences

Promethera Biosciences is a biopharmaceutical company focused on cell therapyproducts to treat liver diseases.
Edit Profile
More info

Elsewhere

Companies in the same industry

Complexa Complexa Clearside BioMedical, Inc. Clearside BioMedical, Inc. Mersana Therapeutics Mersana Therapeutics Hengrui Therapeutics, Inc. Hengrui Therapeutics, Inc. Allinaire Therapeutics Allinaire Therapeutics Vividion Therapeutics Vividion Therapeutics Atterx Biotherapeutics Atterx Biotherapeutics ArGEN-X ArGEN-X CoDa Therapeutics, Inc. CoDa Therapeutics, Inc. 3-V Biosciences 3-V Biosciences

Alexa global traffic share

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 4
Add info
27 Oct 2016
€10,000,000
Venture capital (Series C)
Mitsubishi UFJ Capital, Vesalius Biocapital Partners, Boehringer Ingelheim Venture Fund, +4

Promethera Biosciences Raises EUR 10 Million in a Series C-extension Financing to Advance its Broad Product Pipeline in Liver Diseases | Business Wire

businesswire
25 Nov 2014
$31,444,456
Venture capital (Series C)
28 Mar 2012
$31,475,320
Venture capital (Series B)
Mitsui & Co. Global Investment, Boehringer Ingelheim Venture Fund, Shire
02 Feb 2010
$7,300,000
Venture capital (Series A)
Life Sciences Partners, Vesalius Biocapital Partners, Société Régionale d'Investissement de Wallonie